메뉴 건너뛰기
Hepatology International
Volumn 5, Issue 4, 2011, Pages 876-881
Prevention of post liver transplant HBV recurrence
Author keywords

Adefovir; Entecavir; HBIG; HBV recurrence; Lamivudine; Liver transplantation; Tenofovir
Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; EMTRICITABINE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ENTECAVIR; HEPATITIS B ANTIBODY; LAMIVUDINE; NUCLEOSIDE ANALOG; NUCLEOTIDE DERIVATIVE; TENOFOVIR;
EID: 81855175878     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-011-9293-8     Document Type: Review
Times cited : (4)
References (52)
  • 1
    • 0034078342 scopus 로고    scopus 로고
    • Hepatitis B: An important public health issue
    • DOI 10.1002/1096-9071(200007)61:3<362::AID-JMV14>3.0.CO;2-I
    • WC Maddrey 2000 Hepatitis B: an important public health issue J Med Virol 61 362 366 10861647 10.1002/1096-9071(200007)61:3<362::AID-JMV14>3.0. CO;2-I 1:STN:280:DC%2BD3cvgsFChsA%3D%3D (Pubitemid 30368539)
    • (2000) Journal of Medical Virology , vol.61 , Issue.3 , pp. 362-366
    • Maddrey, W.C.1
  • 2
    • 0642303165 scopus 로고    scopus 로고
    • The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update
    • 14623619
    • HB El-Serag JA Davila NJ Petersen, et al. 2003 The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 139 817 823 14623619
    • (2003) Ann Intern Med , vol.139 , pp. 817-823
    • El-Serag, H.B.1    Davila, J.A.2    Petersen, N.J.3
  • 3
    • 58849151464 scopus 로고    scopus 로고
    • Do we really need long-term hepatitis B hyperimmune globulin? What are the alternatives?
    • 18825722 10.1002/lt.21637
    • JR Lake 2008 Do we really need long-term hepatitis B hyperimmune globulin? What are the alternatives? Liver Transpl 14 S23 S26 18825722 10.1002/lt.21637
    • (2008) Liver Transpl , vol.14
    • Lake, J.R.1
  • 4
    • 77954944543 scopus 로고
    • Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation
    • 10.1111/j.1600-6143.2010.03046.x
    • B Degertekin SH Han EB Keeffe, et al. 1823 Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation Am J Transplant 10 1823 1833 10.1111/j.1600-6143.2010.03046.x
    • (1823) Am J Transplant , vol.10 , pp. 1823-1833
    • Degertekin, B.1    Han, S.H.2    Keeffe, E.B.3
  • 5
    • 0028105816 scopus 로고
    • Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease
    • Marcellin P, Samuel D, Areias J, et al. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease. Hepatology 1994; (1):6-12
    • (1994) Hepatology , Issue.1 , pp. 6-12
    • Marcellin, P.1    Samuel, D.2    Areias, J.3
  • 6
    • 58849105113 scopus 로고    scopus 로고
    • Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosis
    • 18825719 10.1002/lt.21615
    • F Zoulim S Radenne C Ducerf 2008 Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosis Liver Transpl 14 S1 S7 18825719 10.1002/lt.21615
    • (2008) Liver Transpl , vol.14
    • Zoulim, F.1    Radenne, S.2    Ducerf, C.3
  • 8
    • 0034927065 scopus 로고    scopus 로고
    • Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort
    • DOI 10.1053/jhep.2001.26512
    • FY Yao NA Terrault C Freise, et al. 2001 Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort Hepatology 34 411 416 11481627 10.1053/jhep.2001.26512 1:CAS:528:DC%2BD3MXmtVGqtLk%3D (Pubitemid 32702355)
    • (2001) Hepatology , vol.34 , Issue.2 , pp. 411-416
    • Yao, F.Y.1    Terrault, N.A.2    Freise, C.3    Maslow, L.4    Bass, N.M.5
  • 11
    • 58849089061 scopus 로고    scopus 로고
    • How to diagnose and treat hepatitis B virus antiviral drug resistance in the liver transplant setting
    • 18825720 10.1002/lt.21616
    • AS Lok 2008 How to diagnose and treat hepatitis B virus antiviral drug resistance in the liver transplant setting Liver Transpl 14 S8 S14 18825720 10.1002/lt.21616
    • (2008) Liver Transpl , vol.14
    • Lok, A.S.1
  • 15
    • 77957331059 scopus 로고    scopus 로고
    • Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: A systematic review and Bayesian meta-analyses
    • 20600036 10.1053/j.gastro.2010.06.042 1:CAS:528:DC%2BC3cXht1CgtrzN
    • G Woo G Tomlinson Y Nishikawa, et al. 2010 Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses Gastroenterology 139 1218 1229 20600036 10.1053/j.gastro.2010.06.042 1:CAS:528:DC%2BC3cXht1CgtrzN
    • (2010) Gastroenterology , vol.139 , pp. 1218-1229
    • Woo, G.1    Tomlinson, G.2    Nishikawa, Y.3
  • 16
    • 78751491184 scopus 로고    scopus 로고
    • Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease
    • 21254162 10.1002/hep.23952 1:CAS:528:DC%2BC3MXitVeksrk%3D
    • YF Liaw IS Sheen CM Lee, et al. 2011 Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease Hepatology 53 62 72 21254162 10.1002/hep.23952 1:CAS:528:DC%2BC3MXitVeksrk%3D
    • (2011) Hepatology , vol.53 , pp. 62-72
    • Liaw, Y.F.1    Sheen, I.S.2    Lee, C.M.3
  • 17
    • 79952211991 scopus 로고    scopus 로고
    • Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure
    • Garg H, Sarin SK, Kumar M, et al. (2011) Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology
    • (2011) Hepatology
    • Garg, H.1    Sarin, S.K.2    Kumar, M.3
  • 18
    • 75349107764 scopus 로고    scopus 로고
    • Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis
    • 20006394 10.1016/j.jhep.2009.11.007
    • JH Shim HC Lee KM Kim, et al. 2009 Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis J Hepatol 52 176 182 20006394 10.1016/j.jhep.2009.11.007
    • (2009) J Hepatol , vol.52 , pp. 176-182
    • Shim, J.H.1    Lee, H.C.2    Kim, K.M.3
  • 19
    • 73149085984 scopus 로고    scopus 로고
    • Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function
    • 19937695 10.1002/hep.23346 1:CAS:528:DC%2BD1MXhs1SjurnN
    • CM Lange J Bojunga WP Hofmann, et al. 2009 Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function Hepatology 50 6 2001 2006 19937695 10.1002/hep.23346 1:CAS:528:DC%2BD1MXhs1SjurnN
    • (2009) Hepatology , vol.50 , Issue.6 , pp. 2001-2006
    • Lange, C.M.1    Bojunga, J.2    Hofmann, W.P.3
  • 20
    • 78751590984 scopus 로고    scopus 로고
    • Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B
    • 21030105 10.1016/j.jhep.2010.06.043 1:CAS:528:DC%2BC3MXmsVylug%3D%3D
    • VW Wong GL Wong KK Yiu, et al. 2011 Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B J Hepatol 54 2 236 242 21030105 10.1016/j.jhep.2010.06.043 1:CAS:528:DC%2BC3MXmsVylug%3D%3D
    • (2011) J Hepatol , vol.54 , Issue.2 , pp. 236-242
    • Wong, V.W.1    Wong, G.L.2    Yiu, K.K.3
  • 21
    • 79959551969 scopus 로고    scopus 로고
    • Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized open-label study
    • Liaw YF, Raptopoulou-Gigi M, Cheinquer H, et al. (2011) Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized open-label study. Hepatology
    • (2011) Hepatology
    • Liaw, Y.F.1    Raptopoulou-Gigi, M.2    Cheinquer, H.3
  • 22
    • 0025898609 scopus 로고
    • Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients
    • 1672913 10.1016/0140-6736(91)92515-4 1:STN:280:DyaK3M7psVChuw%3D%3D
    • D Samuel A Bismuth D Mathieu, et al. 1991 Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients Lancet 337 813 815 1672913 10.1016/0140-6736(91)92515-4 1:STN:280:DyaK3M7psVChuw%3D%3D
    • (1991) Lancet , vol.337 , pp. 813-815
    • Samuel, D.1    Bismuth, A.2    Mathieu, D.3
  • 24
    • 0028836094 scopus 로고
    • Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation
    • 10.1002/hep.1840210104 199521
    • PW Angus SA Locarnini GW McCaughan, et al. 1995 Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation Hepatology 199521 14 18 10.1002/hep.1840210104
    • (1995) Hepatology , pp. 14-18
    • Angus, P.W.1    Locarnini, S.A.2    McCaughan, G.W.3
  • 25
    • 0029860096 scopus 로고    scopus 로고
    • Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation
    • DOI 10.1053/jhep.1996.v24.pm0008938164
    • JS McMillan DS Bowden PW Angus, et al. 1996 Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation Hepatology 24 1371 1378 8938164 10.1002/hep.510240610 1:CAS:528:DyaK2sXpt1Cmtw%3D%3D (Pubitemid 26399033)
    • (1996) Hepatology , vol.24 , Issue.6 , pp. 1371-1378
    • Mcmillan, J.S.1    Bowden, D.S.2    Angus, P.W.3    Mccaughan, G.W.4    Locarnini, S.A.5
  • 29
    • 0037219194 scopus 로고    scopus 로고
    • Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B
    • DOI 10.1053/jhep.2003.50035
    • CM Lo JT Fung GK Lau, et al. 2003 Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B Hepatology 37 36 43 12500186 10.1053/jhep.2003.50035 1:CAS:528:DC%2BD3sXovVWitA%3D%3D (Pubitemid 36042142)
    • (2003) Hepatology , vol.37 , Issue.1 , pp. 36-43
    • Lo, C.-M.1    Fung, J.T.-K.2    Lau, G.K.-K.3    Liu, C.-L.4    Cheung, S.-T.5    Lai, C.-L.6    Fan, S.-T.7    Wong, J.8
  • 30
    • 33846244229 scopus 로고    scopus 로고
    • Identification of hepatitis B virus-specific lymphocytes in human liver grafts from HBV-immune donors
    • DOI 10.1002/lt.20887
    • Y Luo CM Lo CK Cheung, et al. 2007 Identification of hepatitis B virus-specific lymphocytes in human liver grafts from HBV-immune donors Liver Transpl 13 71 79 17031830 10.1002/lt.20887 (Pubitemid 46099976)
    • (2007) Liver Transplantation , vol.13 , Issue.1 , pp. 71-79
    • Luo, Y.1    Lo, C.M.2    Cheung, C.K.3    Lau, G.K.4    Fan, S.T.5    Wong, J.6
  • 33
    • 0033743167 scopus 로고    scopus 로고
    • An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy
    • 11084061 10.1053/jlts.2000.18702 1:STN:280:DC%2BD3M%2FmtlGisw%3D%3D
    • SH Han J Ofman C Holt, et al. 2000 An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy Liver Transpl 6 6 741 748 11084061 10.1053/jlts.2000.18702 1:STN:280:DC%2BD3M%2FmtlGisw%3D%3D
    • (2000) Liver Transpl , vol.6 , Issue.6 , pp. 741-748
    • Han, S.H.1    Ofman, J.2    Holt, C.3
  • 34
    • 0033944122 scopus 로고    scopus 로고
    • Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B
    • PW Angus GW McCaughan EJ Gane, et al. 2000 Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B Liver Transpl 6 429 433 10915163 10.1053/jlts.2000.8310 1:STN:280:DC%2BD3M%2FitVOjtg%3D%3D (Pubitemid 30489114)
    • (2000) Liver Transplantation , vol.6 , Issue.4 , pp. 429-433
    • Angus, P.W.1    McCaughan, G.W.2    Gane, E.J.3    Crawford, D.H.G.4    Harley, H.5
  • 35
    • 33947304026 scopus 로고    scopus 로고
    • Lamivudine Plus Low-Dose Hepatitis B Immunoglobulin to Prevent Recurrent Hepatitis B Following Liver Transplantation
    • DOI 10.1053/j.gastro.2007.01.005, PII S0016508507000078
    • EJ Gane PW Angus S Strasser, et al. 2007 Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation Gastroenterology 132 931 937 17383422 10.1053/j.gastro.2007.01. 005 1:CAS:528:DC%2BD2sXkslCjurY%3D (Pubitemid 46440868)
    • (2007) Gastroenterology , vol.132 , Issue.3 , pp. 931-937
    • Gane, E.J.1    Angus, P.W.2    Strasser, S.3    Crawford, D.H.G.4    Ring, J.5    Jeffrey, G.P.6    McCaughan, G.W.7
  • 36
    • 33645079411 scopus 로고    scopus 로고
    • Prophylactic use of low-dose, on-demand, intramuscular hepatitis B immunoglobulin and lamivudine after liver transplantation
    • 16549180 10.1016/j.transproceed.2005.12.063 1:CAS:528: DC%2BD28Xis1aqt78%3D
    • S Karademir H Astarcioglu M Akarsu, et al. 2006 Prophylactic use of low-dose, on-demand, intramuscular hepatitis B immunoglobulin and lamivudine after liver transplantation Transplant Proc 38 579 583 16549180 10.1016/j.transproceed.2005.12.063 1:CAS:528:DC%2BD28Xis1aqt78%3D
    • (2006) Transplant Proc , vol.38 , pp. 579-583
    • Karademir, S.1    Astarcioglu, H.2    Akarsu, M.3
  • 38
    • 33646020354 scopus 로고    scopus 로고
    • Hepatitis B prophylaxis post-liver transplant without maintenance hepatitis B immunoglobulin therapy
    • 16640528 10.1111/j.1399-0012.2005.00467.x
    • DS Nath A Kalis S Nelson, et al. 2006 Hepatitis B prophylaxis post-liver transplant without maintenance hepatitis B immunoglobulin therapy Clin Transplant 20 206 210 16640528 10.1111/j.1399-0012.2005.00467.x
    • (2006) Clin Transplant , vol.20 , pp. 206-210
    • Nath, D.S.1    Kalis, A.2    Nelson, S.3
  • 39
    • 56149096190 scopus 로고    scopus 로고
    • A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis
    • 18925641 10.1002/hep.22524 1:CAS:528:DC%2BD1cXhsVKmtrfO
    • PW Angus SJ Patterson SI Strasser, et al. 2008 A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis Hepatology 48 1460 1466 18925641 10.1002/hep.22524 1:CAS:528:DC%2BD1cXhsVKmtrfO
    • (2008) Hepatology , vol.48 , pp. 1460-1466
    • Angus, P.W.1    Patterson, S.J.2    Strasser, S.I.3
  • 40
    • 81855227458 scopus 로고    scopus 로고
    • Posttransplantation hepatitis B prophylaxis with combination oral nucleoside and nucleotide analog therapy
    • S Saab S Desai D Tsaoi, et al. 2011 Posttransplantation hepatitis B prophylaxis with combination oral nucleoside and nucleotide analog therapy Am J Transplant 7 1600 6143
    • (2011) Am J Transplant , vol.7 , pp. 1600-6143
    • Saab, S.1    Desai, S.2    Tsaoi, D.3
  • 41
    • 78349285207 scopus 로고    scopus 로고
    • Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis
    • 21031547 10.1002/lt.22169
    • CK Cheung CM Lo K Man, et al. 2010 Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis Liver Transpl 16 1314 1323 21031547 10.1002/lt.22169
    • (2010) Liver Transpl , vol.16 , pp. 1314-1323
    • Cheung, C.K.1    Lo, C.M.2    Man, K.3
  • 43
    • 0141532308 scopus 로고    scopus 로고
    • Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease
    • DOI 10.1053/jhep.2003.50396
    • U Bienzle M Gunther R Neuhaus, et al. 2003 Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease Hepatology 38 811 819 14512868 1:CAS:528:DC%2BD3sXovFGhtLY%3D (Pubitemid 37221664)
    • (2003) Hepatology , vol.38 , Issue.4 , pp. 811-819
    • Bienzle, U.1    Gunther, M.2    Neuhaus, R.3    Vandepapeliere, P.4    Vollmar, J.5    Lun, A.6    Neuhaus, P.7
  • 44
    • 21844435779 scopus 로고    scopus 로고
    • Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B
    • DOI 10.1016/j.jhep.2005.03.013, PII S0168827805002977
    • CM Lo CL Liu SC Chan, et al. 2005 Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B J Hepatol 43 283 287 15964658 10.1016/j.jhep.2005.03.013 1:CAS:528:DC%2BD2MXlvFals7c%3D (Pubitemid 40956881)
    • (2005) Journal of Hepatology , vol.43 , Issue.2 , pp. 283-287
    • Chung, M.L.1    Chi, L.L.2    See, C.C.3    Lau, G.K.4    Sheung, T.F.5
  • 45
    • 81855177604 scopus 로고    scopus 로고
    • Living related liver transplant (LRLT) in HBV DNA negative cirrhosis without hepatitis B immunoglobulin (HBIG)
    • M Wadhawan S Gupta V Vij, et al. 2011 Living related liver transplant (LRLT) in HBV DNA negative cirrhosis without hepatitis B immunoglobulin (HBIG) Hepatol Int 5 38
    • (2011) Hepatol Int , vol.5 , pp. 38
    • Wadhawan, M.1    Gupta, S.2    Vij, V.3
  • 46
    • 77749323292 scopus 로고    scopus 로고
    • Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: A systematic review
    • 20209589
    • S Saab B Waterman AC Chi, et al. 2010 Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review Liver Transpl 16 300 307 20209589
    • (2010) Liver Transpl , vol.16 , pp. 300-307
    • Saab, S.1    Waterman, B.2    Chi, A.C.3
  • 47
    • 75349089062 scopus 로고    scopus 로고
    • Liver grafts from anti-hepatitis B core positive donors: A systematic review
    • 20034693 10.1016/j.jhep.2009.11.009 1:CAS:528:DC%2BC3cXhs1art7c%3D
    • E Cholongitas GV Papatheodoridis AK Burroughs 2010 Liver grafts from anti-hepatitis B core positive donors: a systematic review J Hepatol 52 272 279 20034693 10.1016/j.jhep.2009.11.009 1:CAS:528:DC%2BC3cXhs1art7c%3D
    • (2010) J Hepatol , vol.52 , pp. 272-279
    • Cholongitas, E.1    Papatheodoridis, G.V.2    Burroughs, A.K.3
  • 48
    • 78650099164 scopus 로고    scopus 로고
    • Virus: An update
    • 20880077 10.1111/j.1478-3231.2010.02320.x
    • S Pascarella F Negro D Hepatitis 2010 virus: an update Liver Int 31 7 21 20880077 10.1111/j.1478-3231.2010.02320.x
    • (2010) Liver Int , vol.31 , pp. 7-21
    • Pascarella, S.1    Negro, F.2    Hepatitis, D.3
  • 49
    • 79251490096 scopus 로고    scopus 로고
    • Peginterferon plus adefovir versus either drug alone for hepatitis delta
    • 21268724 10.1056/NEJMoa0912696 1:CAS:528:DC%2BC3MXhtFygu7o%3D
    • H Wedemeyer C Yurdaydin GN Dalekos, et al. 2011 Peginterferon plus adefovir versus either drug alone for hepatitis delta N Engl J Med 364 322 331 21268724 10.1056/NEJMoa0912696 1:CAS:528:DC%2BC3MXhtFygu7o%3D
    • (2011) N Engl J Med , vol.364 , pp. 322-331
    • Wedemeyer, H.1    Yurdaydin, C.2    Dalekos, G.N.3
  • 50
    • 0028965006 scopus 로고
    • Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis
    • 7843702 10.1002/hep.1840210211 1:STN:280:DyaK2M7ks1SgsQ%3D%3D
    • D Samuel AL Zignego M Reynes, et al. 1995 Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis Hepatology 21 333 339 7843702 10.1002/hep.1840210211 1:STN:280:DyaK2M7ks1SgsQ%3D%3D
    • (1995) Hepatology , vol.21 , pp. 333-339
    • Samuel, D.1    Zignego, A.L.2    Reynes, M.3
  • 52
    • 72949120993 scopus 로고    scopus 로고
    • Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation
    • 19877207 10.1002/lt.21882
    • S Saab M Yeganeh K Nguyen, et al. 2009 Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation Liver Transpl 15 1525 1534 19877207 10.1002/lt.21882
    • (2009) Liver Transpl , vol.15 , pp. 1525-1534
    • Saab, S.1    Yeganeh, M.2    Nguyen, K.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.